Traders sold shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) on strength during trading hours on Friday. $28.94 million flowed into the stock on the tick-up and $62.91 million flowed out of the stock on the tick-down, for a money net flow of $33.97 million out of the stock. Of all equities tracked, Zimmer Biomet Holdings had the 0th highest net out-flow for the day. Zimmer Biomet Holdings traded up $0.77 for the day and closed at $117.93

A number of research firms have recently issued reports on ZBH. Stifel Nicolaus restated a “hold” rating and issued a $125.00 target price on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Needham & Company LLC increased their target price on Zimmer Biomet Holdings from $151.00 to $153.00 and gave the company a “strong-buy” rating in a report on Friday, April 28th. Oppenheimer Holdings, Inc. set a $132.00 target price on Zimmer Biomet Holdings and gave the company a “buy” rating in a report on Friday, April 28th. BMO Capital Markets restated a “buy” rating and issued a $136.00 target price on shares of Zimmer Biomet Holdings in a report on Tuesday, July 11th. Finally, Wells Fargo & Company restated a “market weight” rating on shares of Zimmer Biomet Holdings in a report on Friday, July 14th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $137.76.

The firm has a market cap of $23.80 billion, a PE ratio of 33.59 and a beta of 1.20. The company has a 50-day moving average of $127.65 and a 200-day moving average of $121.39.

Zimmer Biomet Holdings (NYSE:ZBH) last issued its quarterly earnings results on Thursday, July 27th. The medical equipment provider reported $2.08 EPS for the quarter, missing the consensus estimate of $2.10 by $0.02. Zimmer Biomet Holdings had a return on equity of 16.70% and a net margin of 9.12%. The business had revenue of $1.95 billion for the quarter, compared to the consensus estimate of $1.95 billion. During the same period last year, the firm earned $2.02 earnings per share. The company’s quarterly revenue was up 1.1% compared to the same quarter last year. On average, analysts anticipate that Zimmer Biomet Holdings, Inc. will post $8.24 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Friday, July 28th. Shareholders of record on Friday, June 23rd were given a dividend of $0.24 per share. The ex-dividend date of this dividend was Wednesday, June 21st. This represents a $0.96 annualized dividend and a yield of 0.81%. Zimmer Biomet Holdings’s dividend payout ratio (DPR) is presently 27.59%.

In other Zimmer Biomet Holdings news, VP Tony W. Collins sold 16,986 shares of the business’s stock in a transaction dated Monday, July 31st. The shares were sold at an average price of $121.74, for a total transaction of $2,067,875.64. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Sang Yi sold 17,731 shares of the business’s stock in a transaction dated Monday, June 12th. The stock was sold at an average price of $124.56, for a total transaction of $2,208,573.36. The disclosure for this sale can be found here. Insiders own 1.07% of the company’s stock.

A number of large investors have recently modified their holdings of the company. Parkside Financial Bank & Trust boosted its stake in shares of Zimmer Biomet Holdings by 2.7% in the first quarter. Parkside Financial Bank & Trust now owns 839 shares of the medical equipment provider’s stock valued at $102,000 after buying an additional 22 shares during the period. Parallel Advisors LLC boosted its stake in shares of Zimmer Biomet Holdings by 20.8% in the first quarter. Parallel Advisors LLC now owns 1,157 shares of the medical equipment provider’s stock valued at $138,000 after buying an additional 199 shares during the period. IHT Wealth Management LLC boosted its stake in shares of Zimmer Biomet Holdings by 28.4% in the first quarter. IHT Wealth Management LLC now owns 1,158 shares of the medical equipment provider’s stock valued at $139,000 after buying an additional 256 shares during the period. Sandy Spring Bank boosted its stake in shares of Zimmer Biomet Holdings by 1.7% in the first quarter. Sandy Spring Bank now owns 1,222 shares of the medical equipment provider’s stock valued at $149,000 after buying an additional 20 shares during the period. Finally, Ledyard National Bank boosted its stake in shares of Zimmer Biomet Holdings by 9.3% in the first quarter. Ledyard National Bank now owns 1,293 shares of the medical equipment provider’s stock valued at $157,000 after buying an additional 110 shares during the period. 84.13% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION WARNING: “Investors Sell Zimmer Biomet Holdings, Inc. (NYSE:ZBH) on Strength (NYSE:ZBH)” was reported by Daily Political and is the property of of Daily Political. If you are reading this report on another publication, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be viewed at https://www.dailypolitical.com/2017/08/06/investors-sell-zimmer-biomet-holdings-inc-nysezbh-on-strength-nysezbh.html.

Zimmer Biomet Holdings Company Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.